Change Eligibility Rules for More Diverse Clinical Trials?
Expanding eligibility criteria is a strategy for improving the inclusion of traditionally…
Navigating Policy Terrain: Perspectives for Payers on Tackling Ghost Networks
It’s not uncommon for a patient, when searching their insurer’s provider directory,…
FDA issues warning letter to Philips regarding manufacturing facility
Philips received a warning letter from the FDA in February, which the…
Amgen obesity drug MariTide: four key questions going forward
Amgen’s comments Thursday that it’s “very encouraged” by interim Phase 2 data…
New approach for developing cancer vaccines could make immunotherapies more effective in acute myeloid leukemia
UChicago Pritzker School of Molecular Engineering PhD candidate Anna Slezak is first…
Inflammatory disease not major risk factors for severe COVID-19, focus on comorbidities urged
In a recent study published in The Lancet Digital Health, a group…
Jump-Start Your Exercise With This Mindset Reset
May 3, 2024 – There are plenty of reasons to exercise, but…
MicroRNAs Predict Pancreatic Cancer Risk Years in Advance
TOPLINE:Researchers have identified specific circulating microRNAs (miRNAs) in blood samples that can…
Amgen Puts Its Weight Behind Obesity Drug With Potential Edge Over Lilly, Novo Nordisk Meds
Amgen aims to challenge the Novo Nordisk and Eli Lilly duopoly in…